CORDIS · 716677 · H2020
MGUS screening RCT Screening for monoclonal gammopathy of undetermined significance: A population-based randomized clinical trial
Coordinator: HASKOLI ISLANDS (IS)
Monoclonal gammopathy of undetermined significance (MGUS) is a very common precursor condition to multiple myeloma (MM), and related diseases, and can be found in approximately 4-5% of individuals over the age of 50 years. MM is always preceded by MGUS. Current risk stratification schemes, designed to predict those that will progress, are based on retrospective data and rely almost solely on serum protein markers. While they can differentiate high and low-risk patients, they cannot predict outcome for individual patients, are not integrated with one another, and have limited biological correl…
About Horizon 2020 (2014–2020)
Horizon 2020 was the EU's flagship research and innovation programme for 2014–2020, with a budget of around €77 billion. It bundled FP7's strands with the EIT and the Competitiveness and Innovation Programme, introduced a stronger societal-challenge orientation, and pushed the funding logic toward closer-to-market innovation. New calls closed in 2020 but funded projects continued through 2024.
EU contribution: €1.5M awarded to the consortium. The project runs over approximately 5 years from 2017-02-01 to 2022-01-31.
Full record on CORDIS — partners, deliverables, publications, news.
Open on cordis.europa.eu → Grant DOI ↗More from IS
see all →- WHISPER — Wind Energy Harvesting for Ship Propulsion Assistance and Power101096577 · HORIZON · €9.0M
- MarineGuardian — Advancing Sustainable Fisheries and Marine Ecosystem Conservation in the Atlantic and Arctic Sea basin101212608 · HORIZON · €8.0M
- BioProtect — ADVANCING AREA-BASED MANAGEMENT TOOLS TO ACCELERATE THE PROTECTION AND RESTORATION OF MARINE BIODIVERSITY ACROSS THE EUROPEAN SEA BASINS101157341 · HORIZON · €8.0M
- FUTUREVOLC — A European volcanological supersite in Iceland: a monitoring system and network for the future308377 · FP7 · €6.0M
- FarFish — Responsive Results-Based Management and capacity building for EU Sustainable Fisheries Partnership Agreement- and international waters727891 · H2020 · €5.0M
- LIBBIO — Lupinus mutabilis for Increased Biomass from marginal lands and value for BIOrefineries720726 · H2020 · €4.9M
Other H2020 projects
see all →- EUROfusion — Implementation of activities described in the Roadmap to Fusion during Horizon 2020 through a Joint programme of the members of the EUROfusion consortium633053 · DE · €678.8M
- H2020 — COST at a turning point: A unique framework for pan-European ST cooperation as clear demonstration of European values681463 · BE · €178.2M
- HBP SGA3 — Human Brain Project Specific Grant Agreement 3945539 · BE · €150.0M
- COVID-19 VACCINES — PROPOSAL FOR FUNDING RESEARCH DEVELOPMENT AND MANUFACTURING OF VACCINE AGAINST COVID-19101018100 · NO · €100.0M
- UNITE4TB — ACADEMIA AND INDUSTRY UNITED INNOVATION AND TREATMENT FOR TUBERCULOSIS101007873 · NL · €92.5M
- ERA4TB — EUROPEAN REGIMEN ACCELERATOR FOR TUBERCULOSIS853989 · ES · €89.8M
Frequently asked questions
- Who funds this research project?
- This project is funded by the European Union through the Horizon 2020 (2014–2020) programme, under the ERC-STG funding scheme.
- What is the EU contribution?
- The European Commission contributes €1.5M toward a total project budget of €1.5M.
- Which EU programme funds it?
- The project is funded under Horizon 2020 (2014–2020), call ERC-2016-STG.
- Who coordinates the project?
- The project is coordinated by HASKOLI ISLANDS (IS).
- What is the project timeline?
- The project runs from 2017-02-01 to 2022-01-31 — approximately 5 years.
- Where can I find the full project record?
- The complete record — partners, deliverables, publications and news — is published on CORDIS under project ID 716677.